Efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) once weekly in participants with overweight or obesity (NN9838-4608)
Team: Daniel Bessesen, Jeanne Anne Breen, Debbie Bochert, April Hamilton
(link to an external website with info on the study?)
